ReutersThe scrip opened at Rs 2459.0 and touched an intraday high and low of Rs 2475.45 and Rs 2449.4, respectively, in the session so far. Shares of the company of SRF Ltd. quoted a 52-week high of Rs 2864.35 and a 52-week low of Rs 2050.0.
As per BSE, the total market cap of the SRF Ltd. stood at Rs 72892.35 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 3350.14 crore for the quarter ended 30-Jun-2023, down 11.85 per cent from previous quarter's Rs 3800.42 crore and down 14.2 per cent from the year-ago quarter's Rs 3904.57 crore.
The net profit for latest quarter stood at Rs 359.29 crore, down 40.91 per cent from the same quarter a year ago.
As of 30-Jun-2023, DIIs held 7.29 per cent stake in the company, while foreign institutional investors held 20.03 per cent and the promoters 50.53 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 38.09 and a price-to-book ratio of 6.93. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
SRF Ltd. belongs to the Diversified industry.
Friday, 08 Sep, 2023- Front Page
- Pure Politics
- ET Markets
- Smart Investing
- Learn more about our print editionMore
IT Hardware Imports Surge in Aug after Licensing OrderIndia’s IT hardware imports surged as much as 50% in August from July, ahead of licensing rules taking effect on November 1. Companies advanced procurements fearing a supply crunch, said manufacturers and a leading system integrator that buys from distributors and producers and supplies to enterprises.
‘Look to Export AI Products from Nvidia India Arm’Nvidia, the world’s pre-eminent maker of hardware and software for artificial intelligence tools, envisions exporting AI products from its Indian arm, CEO and co-founder of the $27-billion firm, Jensen Huang told researchers at India’s top technology institutes this week, according to the people present at the interaction.
DCGI Collating Data of Pharma PlantsAfter a major drive by the government against spurious and substandard drugs, India’s drug regulator has started collating and compiling the profiles of pharmaceutical plants in the country.The Drug Controller General of India (DCGI) has asked drug companies to provide details of each of their units operational in the country.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: Sensex Today Live, SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Get Unlimited Access to The Economic Times 
